Advanced Therapeutics Pharmaceutical Outsourcing IndustryFuture Market Insights (FMI), a leading provider of industry analysis and market research, has unveiled its latest report highlighting the ...
Japan’s ceramide landscape unites traditional botanical expertise with cutting-edge R&D, spurring novel product categories across skincare, functional foods, and nutraceuticals that cater to consumers ...
Active Ingredients market Surges with Innovations in Pharma, Cosmetics, and Agriculture, Driven by Demand for Sustainability, Natural Products & New Tech.
MANILA, Philippines — Chief Presidential Legal Counsel Juan Ponce Enrile warned that the country would face a “very detrimental precedent” if Filipinos followed the implied reasoning of the ...
Berenberg Bank analyst Richard Hatch maintained a Buy rating on Croda International (CRDA – Research Report) yesterday and set a price target of £38.00. The company’s shares closed yesterday ...
Croda manufactures speciality and industrial chemicals used in many everyday items. Its products can be found in cosmetic creams and lotions, dietary supplements, various foods, plastic bags and ...
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
Each year at the J.P. Morgan Healthcare Conference, pharma CEOs are tasked with assuring and convincing investors that they’ve positioned their companies to overcome expected challenges.
India has been traditionally quite strong in the pharma sector, with a low cost of manufacturing (30%–35% lower than in the US and Europe), cost-efficient R&D (about 87% less than in developed markets ...
(Image Credits: Pixabay) Amid the growing burden of non-communicable diseases and ageing population, the pharmaceutical sector has thrived tremendously over the recent years. Industry leaders ...
Overall, biopharma layoffs rose ever so slightly in 2024 compared to the year before, though the number of layoff rounds across Big Pharma skyrocketed by 281%. In 2024, Fierce Biotech reported 192 ...